Bausch + Lomb, the eyecare business of Bausch Health, is preparing to launch in the U.S. the sale of its trademark Bausch + Lomb Infuse daily disposable silicone hydrogel (SiHydaily) contact lenses in the second half of the year, after receiving clearance from the U.S. Food and Drug Administration (FDA). The new lenses feature a next generation contact lens material, kalifilcon A, designed to address problems with lens dryness, and to offer “outstanding breathability for healthy lens wear while providing exceptional all-day comfort and high definition optics.”